Hence for this study we used a well-characterised breast cancer cell line MDA-MB-231 clone 16, which has been shown to have very high TG2 expression, is more migratory and more resistant to doxorubicin, compared to its wild type cell line [15]. The gene discussed is TGM2; the disease is breast cancer.